Cancer Family
Malignant Mesothelioma
CI-CAN-00000240Explore in graph →
Top-level96 active trials4 approved drugs11 evidence items
- NCIt
- C4456
- ICD-10
- C45
- DOID
- 1790
- MeSH
- D000086002
- MeSH
- D008654
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000240Explore in graph →
Clinical trials
478 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (81)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00509041 | Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT00004183 | Capecitabine in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 27 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00053885 | PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma | completed | Phase 2 | 47 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT02603315 | Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)(VITMPM) | completed | — | 50 | Ain Shams UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT00469196 | Tomotherapy Treatment for Mesothelioma | completed | Phase 2 | 18 | AHS Cancer Control AlbertaOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT00398138 | Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | completed | Phase 1 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 2, 2016 | clinicaltrials |
| NCT00004547 | Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy | completed | Phase 2 | 188 | National Cancer Institute (NCI)NIH | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00402766 | Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma | completed | Phase 1 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01212367 | Intrapleural Gene Transfer for Pleural Mesothelioma(IFN-alpha) | completed | Phase 1 | 13 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT02467426 | Isolated Thoracic Perfusion (ITP-F) for MPM | completed | — | 23 | Medias Klinikum for Surgical OncologyOTHER | 0 | Jun 10, 2015 | clinicaltrials |
| NCT01024946 | Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity | completed | Phase 2 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00006981 | Immunotoxin Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00066651 | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00019825 | Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00459862 | Pazopanib in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 34 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2015 | clinicaltrials |
| NCT00634205 | Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma | completed | Phase 2 | 45 | European Lung Cancer Working PartyOTHER | 2 | Feb 12, 2015 | clinicaltrials |
| NCT00513877 | Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 33 | Cancer Trials IrelandNETWORK | 4 | Dec 31, 2014 | clinicaltrials |
| NCT00867711 | Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients | completed | — | 121 | Istituto Clinico HumanitasOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00309946 | Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | completed | Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2014 | clinicaltrials |
| NCT00325494 | A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer | completed | Phase 1 | 24 | MorphotekINDUSTRY | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00392444 | Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00165516 | Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate | completed | Phase 2 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | completed | Phase 1 | 70 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00897247 | Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | completed | — | 494 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT01241682 | Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma(PMR-MM-002) | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00027703 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 106 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2014 | clinicaltrials |
| NCT02029105 | Serum Biomarkers in Diagnosis of Mesothelioma | completed | — | 230 | Eskisehir Osmangazi UniversityOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00006231 | Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma | completed | Phase 3 | 44 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00075699 | Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 3 | 840 | Medical Research CouncilOTHER_GOV | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00002608 | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | completed | Phase 2 | 30 | Ottawa Regional Cancer CentreOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00821860 | Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma(MesoVATS) | completed | Phase 3 | 196 | Papworth Hospital NHS Foundation TrustOTHER_GOV | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00062283 | Alanosine in Treating Patients With Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00005636 | Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | completed | Phase 3 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00107432 | Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00006014 | SU5416 in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00003263 | Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 1 | 6 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00039182 | Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00025207 | Gefitinib in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00003723 | S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | completed | Phase 2 | 57 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00004254 | Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00004920 | Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | completed | Phase 3 | 256 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jul 18, 2012 | clinicaltrials |
| NCT00227630 | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 59 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 18, 2012 | clinicaltrials |
| NCT00787410 | An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma | completed | Phase 2 | 23 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT00030745 | Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung | completed | Phase 2 | 61 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00020124 | Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00137826 | Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma | completed | Phase 2 | 37 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 26, 2011 | clinicaltrials |
| NCT00407459 | Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma | completed | Phase 2 | 77 | Armando Santoro, MDOTHER | 1 | Sep 2, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Aug 11, 2016source: clinicaltrials